Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Cumpston

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cytotherapy|October 18, 2015
Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor useLauren Veltri, Aaron Cumpston, Alexandra Shillingburg, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 6, 2026
Refractory Burkitt Lymphoma Responding to an Accelerated Ramp-up of Glofitamab With PolatuzumabSyed Abdul Mannan Shah, Aaron Cumpston, Huda Elzahrany, et al.
Transplantation and Cellular Therapy|June 19, 2026
Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma - a Phase II StudyCarl Shultz, Shreyas Shirodkar, Chelby Wakefield, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2013
Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantationSherri Rauenzahn, Quoc Truong, Aaron Cumpston, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 9, 2020
Prospective assessment of Clostridioides (formerly Clostridium) difficile colonization and acquisition in hematopoietic stem cell transplant patientsKristin Austin, Michael Sweet, Eric Likar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host diseaseMehdi Hamadani, Laura F Gibson, Scot C Remick, et al.
Hematology/Oncology and Stem Cell Therapy|December 27, 2011
Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantationAbraham Sebastian Kanate, Michael Craig, Aaron Cumpston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2012
Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapiesMehdi Hamadani, S Thomas Kochuparambil, Salman Osman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2019
Comparison of Graft Acquisition and Early Direct Charges of Haploidentical Related Donor Transplantation versus Umbilical Cord Blood TransplantationAbraham S Kanate, Aniko Szabo, Renju V Raj, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2016
Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin LymphomaBinod Dhakal, Lauren Westfall Veltri, Timothy S Fenske, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cytotherapy|October 18, 2015
Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor useLauren Veltri, Aaron Cumpston, Alexandra Shillingburg, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 6, 2026
Refractory Burkitt Lymphoma Responding to an Accelerated Ramp-up of Glofitamab With PolatuzumabSyed Abdul Mannan Shah, Aaron Cumpston, Huda Elzahrany, et al.
Transplantation and Cellular Therapy|June 19, 2026
Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma - a Phase II StudyCarl Shultz, Shreyas Shirodkar, Chelby Wakefield, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2013
Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantationSherri Rauenzahn, Quoc Truong, Aaron Cumpston, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 9, 2020
Prospective assessment of Clostridioides (formerly Clostridium) difficile colonization and acquisition in hematopoietic stem cell transplant patientsKristin Austin, Michael Sweet, Eric Likar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host diseaseMehdi Hamadani, Laura F Gibson, Scot C Remick, et al.
Hematology/Oncology and Stem Cell Therapy|December 27, 2011
Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantationAbraham Sebastian Kanate, Michael Craig, Aaron Cumpston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2012
Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapiesMehdi Hamadani, S Thomas Kochuparambil, Salman Osman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2019
Comparison of Graft Acquisition and Early Direct Charges of Haploidentical Related Donor Transplantation versus Umbilical Cord Blood TransplantationAbraham S Kanate, Aniko Szabo, Renju V Raj, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2016
Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin LymphomaBinod Dhakal, Lauren Westfall Veltri, Timothy S Fenske, et al.
Pageof 5